CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Watson Laboratories Inc.

1:11-cv-01112

Overview

Case Number 1:11-cv-01112
Filing Date 2011-11-09
Status Terminated
Termination Date 2014-08-04
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Watson Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Novartis AG Operating Company

Represented By

2 Attorneys Listed

Novartis Pharmaceuticals Corporation Operating Company

Represented By

2 Attorneys Listed

Plaintiff

Novartis Pharma AG Operating Company

Represented By

2 Attorneys Listed

Counter Claimant

Watson Pharma Inc. Operating Company

Represented By

2 Attorneys Listed

Watson Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Counter Defendant

LTS Lohmann Therapie-Systeme AG Operating Company

Represented By

2 Attorneys Listed

Novartis International Pharmaceutical Ltd. Operating Company

Represented By

2 Attorneys Listed

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): 🇩🇪 Germany 🇺🇸 US
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 4
USPTO PTAB Trial 2014-11-13
IPR2015-00268

Mylan Pharmaceuticals Inc. et al. v. Novartis AG et al.

U.S. Continuation Sibling (6335031)
Status: Final Written Decision
USPTO PTAB Trial 2014-11-13
IPR2015-00265

Mylan Pharmaceuticals Inc. et al. v. Novartis AG et al.

U.S. Continuation Sibling (6316023)
Status: Final Written Decision
USPTO PTAB Trial 2014-04-02
IPR2014-00550

Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.

U.S. Continuation Sibling (6335031)
Status: Final Written Decision
USPTO PTAB Trial 2014-04-02
IPR2014-00549

Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.

U.S. Continuation Sibling (6316023)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5602176
Phenyl carbamate
Filed: 1995-06-06
Issued: 1997-02-11
Expired (Term Ended)
Expires: 2015-06-06
US6316023
TTS containing an antioxidant
Filed: 2000-12-20
Issued: 2001-11-13
Expired (Term Ended)
Expires: 2020-12-20
US6335031
TTS containing an antioxidant
Filed: 1999-04-14
Issued: 2002-01-01
Expired (Term Ended)
Expires: 2019-04-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 1 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Submit Proposed Final Judgment to July 17, 2014 - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Ph...
Entry #43 • 2014-07-16 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to Submit an Agreed Upon Form of Final Judgment to Wednesday, July 16, 2014 - filed by LTS Lohmann Therapie-Systeme AG...
Entry #42 • 2014-07-02 Document →
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER & CONSOLIDATION ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 11/9/2012. Amended Ple...
Entry #37 • 2012-02-22 Document →

Docket Entries

(57 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-973353.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(lid) (Entered: 11/10/2011)

Entry #1 • 2011-11-09
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-973353.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(lid) (Entered: 11/10/2011)

Entry #1 • 2011-11-09
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-973353.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(lid) (Entered: 11/10/2011)

Entry #1 • 2011-11-09
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-973353.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(lid) (Entered: 11/10/2011)

Entry #1 • 2011-11-09
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-973353.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(lid) (Entered: 11/10/2011)

Entry #1 • 2011-11-09
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc